P002 Annual Business Meeting and Plenary
DESCRIPTION
During the Annual Business Meeting, hear from the AAD/A’s president Susan C. Taylor, MD, FAAD, Secretary-Treasurer Keyvon Nouri, MD, FAAD and Executive Director & CEO Elizabeth K. Usher, MBA about the AAD/As state of affairs.
INFORMAL DISCUSSION OF ISSUES OF IMPORTANCE FROM THE FLOOR*
Pursuant to the Administrative Regulation of the American Academy of Dermatology and the American Academy of Dermatology Association, during any debate at a membership meeting each speaker must introduce themselves by name and professional position. He or she must also identify any potential conflicts of interest. *No CME Credit.
The plenary session offers attendees the opportunity to hear from renowned experts on topics that impact dermatologists today. Speakers include Academy leadership and award-winning named lecturers.
LEARNING OBJECTIVES
Discuss remarkable changes in health care concerns and changes in educational delivery tools.
SCHEDULE
9:30 AM
In Memoriam
Susan C. Taylor, MD, FAAD
9:30 AM
Annual Business Meeting
Keyvan Nouri, MBA, MD, FAAD
10:00 AM
Welcome
Howard Wooding Rogers, MD, PhD, FAAD
10:05 AM
John Kenney Jr., MD Lifetime Achievement Award and Lectureship: Running to the Pain:How Dermatology offers Hope and Results
Iltefat H. Hamzavi, MD, FAAD
10:25 AM
President's Address
Susan C. Taylor, MD, FAAD
10:40 AM
Lila and Murray Gruber Memorial Cancer Research Award and Lectureship: How Science is Delivering Less Toxic, More Effective Merkel Cell Carcinoma Management
Paul Nghiem, MD, PhD, FAAD
11:00 AM
President-Elect Address
Murad Alam, MD, MSCI, MBA, FAAD
11:15 AM
Marion B. Sulzberger, MD Memorial Award and Lectureship: Anatomic Niches and Immune Convergence: Rethinking Skin Inflammation
Johann E. Gudjonsson, MD, FAAD
11:35 AM
Clarence S. Livingood, MD Memorial Award and Lectureship: Improving Rural Access to Care: Consider the Options
Robert T. Brodell, MD, FAAD
DIRECTOR
Howard Wooding Rogers, MD, PhD, FAAD
SPEAKERS
Murad Alam, MD, MSCI, MBA, FAAD
Northwestern University
Robert T. Brodell, MD, FAAD
University of Mississippi Medical Center
Johann E. Gudjonsson, MD, FAAD
Iltefat H. Hamzavi, MD, FAAD
Paul Nghiem, MD, PhD, FAAD
Keyvan Nouri, MBA, MD, FAAD
Susan C. Taylor, MD, FAAD
HANDOUTS
DISCLOSURES
Murad Alam, MD, MSCI, MBA, FAAD
No financial relationships exist with ineligible companies.
Robert T. Brodell, MD, FAAD
Amgen – Consultant (1099 relationship)(Honoraria); Corrona, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Regeneron – Consultant (1099 relationship)(Honoraria); Sanofi – Investigator(Grants/Research Funding); VeraDermics Inc. – Stockholder(Stock);
Johann E. Gudjonsson, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Eli Lilly – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria), Other(Grants/Research Funding); Genentech, Inc. – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); miRagen Therapeutics, Inc. – Consultant(Honoraria); Novartis – Advisory Board(Fees), Advisory Board(Honoraria), Other(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Zura Bio – Advisory Board(Honoraria);
Iltefat H. Hamzavi, MD, FAAD
AbbVie – Advisory Board(Fees); Almirall – Consultant (1099 relationship)(Fees); Avita – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Advisory Board(Fees); Boehringer Ingelheim – Consultant(Fees); Clinuvel – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Investigator(Grants/Research Funding); Lenicura – Investigator(Equipment); Merck – Investigator(Grants/Research Funding); MyDerm Portal, Inc – Stockholder(Stock); Novartis – Consultant(Fees); Pfizer Inc. – Investigator(Fees); Sonoma Biotherapeutics – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Teva Pharmaceutical Industries Ltd. – Investigator(Fees); UCB – Consultant(Fees); Union Therapeutics – Consultant(Fees); Vimela – Consultant (1099 relationship)(Fees);
Paul Nghiem, MD, PhD, FAAD
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);
Howard Wooding Rogers, MD, PhD, FAAD
Biofrontera AG – Consultant (1099 relationship)(Fees);
Susan C. Taylor, MD, FAAD
AbbVie – Advisory Board(Honoraria); American Academy of Dermatology – Investigator(Grants/Research Funding); Armis Biopharma, Inc. – Advisory Board(Stock Options); CME Outfitters – Speaker/Faculty Education(Honoraria); Dermsquared – Speaker/Faculty Education(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); GloGetter, Inc – Consultant (1099 relationship)(Stock Options); HMP Global – Speaker/Faculty Education(Honoraria); McGraw-Hill Companies – Other(Other Financial Benefit); Medscape – Speaker/Faculty Education(Honoraria); MJH Life Sciences – Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Piction Health – Consultant (1099 relationship)(Stock Options); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); VeraDermics Inc. – Advisory Board(Honoraria);